Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025)

Prestige Consumer Healthcare's Net Margin history runs 16 years deep, the most recent figure standing at 16.47% for Q4 2025.

• On a quarterly basis, Net Margin fell 455.0% year-over-year to 16.47% in Q4 2025; TTM through Dec 2025 was 16.9%, a 223.0% decrease from a year earlier, with the FY2025 full-year figure at 18.86%, up 26.0% from the prior year.
• Net Margin rose to 16.47% in Q4 2025 per PBH's latest filing, from 15.4% in the prior quarter.
• Across five years, Net Margin topped out at 21.46% in Q2 2021 and bottomed at 84.15% in Q1 2023.
• The 5-year median for Net Margin is 18.54% (2024), against an average of 13.18%.
• Across the five-year window, Net Margin slumped 10366 bps in 2023 and surged 10200 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 18.3% in 2021, then increased by 3 bps to 18.86% in 2022, then slipped by 0 bps to 18.76% in 2023, then rose by 12 bps to 21.02% in 2024, then slipped by 22 bps to 16.47% in 2025.
• Per Business Quant, the three latest PBH Net Margin figures stand at 16.47% (Q4 2025), 15.4% (Q3 2025), and 19.02% (Q2 2025).